Diligence memo · auto-generated · as of July 2, 2026
Metabiota, Inc.
Metabiota, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Metabiota, Inc. operates in Other Health Care, based in SAN FRANCISCO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Metabiota, Inc. has raised $34M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $30M on 2014-12-23.
Most recent recorded round closed around 2014-12-23.
Valuation (modeled)modeled
Provath models Metabiota, Inc. at approximately $669M (range $71M–$2.6B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.51× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 11.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 12.7× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 89% of Other Health Care peers (5377 compared).
Modeled value ranks above 95% of those peers.
Closest niche peers: Drynachan, Llc, Vistria SHC Holdings, LLC, Ebh Holding Company, Inc., Orthopediatrics Corp, Assurerx Health, Inc.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.